This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Viorel Simion, Ph.D
Director of Immunology at Sail Biomedicines
Speaker

Profile

Viorel Simion, PhD, is Director of Immunology at Sail Biomedicines, where he leads cross-functional teams advancing in vivo CAR-T therapies toward IND and drives translational immunology strategy across multiple therapeutic platforms. He brings 15+ years of experience across biotech, pharma, and academia, with expertise in RNA therapeutics, biologics, T-cell engineering and translational biomarker development. His work focuses on engineering next-generation immune interventions for inflammatory and autoimmune disorders.